Promoting remyelination: A case study in regenerative medicine.
Curr Opin Chem Biol
; 70: 102201, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36037558
Therapeutics that modulate regenerative mechanisms by targeting the activity of endogenous (adult) stem cell populations have the potential to revolutionize medicine. In many human disease states, capacity to repair damaged tissue underlies progressive decline and disease progression. Recent insights derived from efforts aimed at promoting remyelination for the treatment of multiple sclerosis (MS) highlight the importance of considering the limiting factors and underlying mechanisms associated with all aspects of disease onset, progression and recovery, during both the discovery and clinical stages of developing a regenerative medicine. This perspective presents general considerations for the development of regenerative therapies, using remyelination as a case study.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Remyelination
/
Multiple Sclerosis
Limits:
Humans
Language:
En
Journal:
Curr Opin Chem Biol
Year:
2022
Document type:
Article